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INTRODUCTION:  Infected  wounds  are  difﬁcult  to  treat and there  are  no  standardized  protocols.
PRESENTATION  OF  CASE:  We  report  a case  of  infected  postoperative  wound  and  entero-cutaneous  ﬁstula  in
a  83  years-old  woman.  An  innovative  treatment  protocol  for Human  amniotic  membrane  (HAM)-assisted
dressing  of  infected  wound  as  the Idea  Stage  following  the  IDEAL  recommendations  is presented.  The
development  of  amnion  preparation  and  the  involved  treatment  steps  are  described.  No  adverse  events
and no  graft  rejection  have  been  detected.
DISCUSSION:  Favorable  results  conﬁrm  the technical  simplicity,  safety  and  efﬁcacy  of  this  procedure.hronic wound
ressing
DEAL recommendations
HAM  has  been  shown  to promote  wound  healing  and  to have  antibacterial  characteristics,  which  was
supported  by the  presented  case.
CONCLUSION:  We  are  able  to report  a successful  treatment  of an  infected  wound  caused  by  entero-
cutaneous  ﬁstula  with  HAM  dressing.  Following  the  IDEAL  recommendations,  consecutive  prospective
cohort  trials  are  justiﬁed.
©  2018  The  Author(s).  Published  by Elsevier  Ltd.  on behalf  of IJS  Publishing  Group  Ltd.  This  is  an  open
he  CCaccess  article  under  t
. Introduction
Chronic wounds have a signiﬁcant impact on public health in
hat they lead to increased disability, morbidity and risk of mortal-
ty and hence result in longer ambulatory and hospital treatments
nd higher costs. Especially diabetic wounds or postoperative
nfected wounds are difﬁcult to treat due to insufﬁcient tissue per-
usion and persistent infection. Chronic wounds are often deﬁned as
ounds that have not achieved a 50% reduction in wound size after
 weeks of standard wound care [1]. However, standardized treat-
ent guidelines are lacking and the outcome/efﬁciency of the on
he market available bioengineered skin substitutes, topical growth
actors and stromal matrices is poor.
Human amniotic membrane (HAM) possesses many interesting
ey properties (e.g. immune tolerance, promotion of epithelial-
zation, anti-inﬂammatory, anti-angiogenetic, anti-ﬁbroblastic and
nti-microbial characteristics), making it a potential scaffold for
∗ Corresponding author at: Lukas Hospital Neuss, Department of Urology,
reussenstr. 84, 41464 Neuss, Germany.
E-mail address: dbarski@lukasneuss.de (D. Barski).
ttps://doi.org/10.1016/j.ijscr.2018.08.015
210-2612/© 2018 The Author(s). Published by Elsevier Ltd. on behalf of IJS Publishing G
reativecommons.org/licenses/by-nc-nd/4.0/). BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
tissue engineering. It contains multiple soluble growth factors that
promote epithelial wound healing and limit the inﬂammatory reac-
tion. Especially the stromal matrix of the HAM has a considerable
inﬂuence on this anti-ﬁbrotic development [2]. Its antibacterial
effects stem from enzymes like elastase. First reports of amnion
application into the pelvic region have shown fast epithelialization
and improved functionality in vaginal and bladder reconstruction
[3–5].
A standardized procedure for the treatment of wound infections
is not available to date. Innovative patient-tailored innovative sur-
gical approaches are difﬁcult to standardize and recommendations
cannot easily be generalized. A new approach, the IDEAL method
has been proposed in 2009 by Mc  Culloch et al. [6]. The IDEAL
procedure clearly provides stages of surgical innovations, which
allow for the ability to assign a new method to its speciﬁc level of
development and evidence. For the ﬁrst time, we present a detailed
treatment protocol with amniotic membrane for an infected wound
as the “Idea level” following the IDEAL recommendations in an aca-
demic hospital setting. The case report is compliant with the SCARE
Guidelines [7]. The presented study was registered at Research
Registry (http://www.researchregistry.com; registration number
4111).
roup Ltd. This is an open access article under the CC BY-NC-ND license (http://
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wig. 1. A. Initial presentation with entero-cutaneous ﬁstula and wound ulceration. B
AM  dressing is marked with an arrow.
. Case report
A retired 83-year-old Caucasian female, BMI 21, non-smoker,
ypertensive, underwent a radical cystectomy with cutaneous
reterostomy for locally invasive bladder cancer (pT2a, G3, N0,
0). Two weeks after surgery she was admitted again to our hos-
ital with a severe infection of the laparotomy wound. Treatment
onsisted of wide resection of subcutaneous tissue with vacuum
ealing followed by a displacement plastic skin repair. A week
ater the patient presented a cutaneous ﬁstula with purulent secre-
ion of 30–50 ml/day. A CT scan revealed communication with a
mall bowel loop. The patient underwent parenteral nutrition and
ctreotid injections for one week, which reduced ﬁstula secretion
o 20–30 ml/day. Due to the complex situation, we  discussed an
ndividualized treatment strategy consisting of off-label use of HAM
ressing. The wound was measured and cleaned. Two-layer amnion
ressing was applied weekly after cleaning and debridement for 4
eeks. A nonadherent inner dressing with wound gauze Cuticell
BSN medical, Hamburg, Germany) covered by a standard dry dress-
ng was then applied over the graft. The patient was  advised not to
emove the dressing and to keep it dry until the next visit. Wound
ize and secretion were documented by taking photographs every
eek. A small biopsy of the wound margin was performed at week
our. The patient provided written consent for treatment, biopsy
nd the use of photographs.
The wound size at the ﬁrst HAM application was
 cm × 2 cm × 1 cm (Fig. 1). Dressings and off-loading were
onducted as described above. After 2 weeks, the secretion
topped and the ulcer diminished in size by 20% (Fig. 1). The
lcer was healed at 8 weeks after 4 HAM applications and the
ound remained healed at 6-month and 9-month follow up. No
omplications occurred during the follow-up and patient reported
o adverse events. Patient was satisﬁed with the treatment and
ould undergo the treatment again retrospectively. Histological
nalysis showed re-epithelialization and muscle cells recovery 4
eeks after the treatment; HAM had not degraded and was  still 2 weeks the secretion stopped and the wound was reduced by 20% and contracted.
detectable as a smooth layer on the surface. Moderate signs of
inﬂammation but no graft rejection were observed (Fig. 2).
3. Discussion
Several randomized trials have demonstrated the effective-
ness of dehydrated human amnionic and chorionic membrane
(dHACM) in the treatment of chronic diabetic foot ulcers (DFUs)
[8]. In a prospective, randomized, single-center clinical trial, Zelen
et al. compared wound reduction and rates of complete healing
in patients with diabetic foot ulcers treated with dHACM versus
standard of care. Signiﬁcant differences in wound reduction were
observed at 4 and 6 weeks, with wounds reducing in size by a mean
of 32.0% ± 47.3% in the standard of care group (n = 12) versus 97.1%
± 7.0% (P < 0.001) for the patients receiving dHACM (n = 13) [9].
Another prospective randomized trial of 40 patients with chronic
DFUs, in whom dHACM allografts were applied weekly, reported a
mean time until complete healing of 2.4 weeks until complete heal-
ing and 90% of DFUs, dHACM allografts were applied weekly [10]. In
the ﬁrst week, the external dressings were changed every other day
due to initial infection of the wound. The amnion acts as a physical
barrier against bacterial contamination and also creates the moist
environment required for healing [11]. However, HAM and dHACM
applications were analyzed in clinically uninfected cases in most of
the reported studies. Only one other study randomized a tissue-
engineered form of wound dressing containing acellular human
amniotic collagen membrane vs. wet dressing in patients with par-
tially infected wounds. The complete healing rate was  signiﬁcantly
higher in the amnion group (40.7%) compared to the control group
(16.7%) [12]. Moreover, HAM was found to be cost-effective in the
treatment of chronic wounds and to reduce hospitalization [10,12].
The limitations of the study is the outcome of one wound in
one patient which is insufﬁcient to draw strong conclusions by
now. However, we  present a structured implementation of a new
method for the secondary wound care with amnion following the
IDEAL recommendations [6]. Considering the positive results of this
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cig. 2. Histological analysis of wound healing. High magniﬁcation (400×) Vimenti
ell  formation (arrows). B. shows muscle cells (arrows) adhering to the scattered pi
rst case we plan consecutive prospective developmental studies
n an animal model and cohort studies.
. Conclusion
In conclusion, we report for the ﬁrst time successful treatment
f an entero-cutaneous ﬁstula and infected wound. HAM is simple
o use, covers larger and irregular surface area wounds and can also
e applied into deep tunneling wounds. Future studies with larger
umbers of patients with infected wounds are warranted and inclu-
ion of amnion dressings in the treatment protocol of secondary
ound care should be considered and further evaluated.
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